Skip to content
Roboearth – Lifestyle
Author:
Humacyte, Inc
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
March 23, 2026
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
March 19, 2026
Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia
March 19, 2026
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair
March 17, 2026
←
Previous Page
1
2